Skip to main content
. 2024 Jan 26;7:131. doi: 10.1038/s42003-024-05826-1

Table 1.

Overview of the data used in this study.

Source_ID Cells Number of patients Stage (FIGO) Tissue (metastatic tumor foci) Histological subtype
OvC0127 30317 3 NA Ovarium, Ascites HGSOC
OvC0213 13950 2 IIB, IIIC Ovarium HGSOC
OvC039 51786 11 IIIC, IVA, IVB Peritoneum, Omentum, Mesentery, Ovarium HGSOC
OvC0460 59738 4 Healthy Fallopian tube fallopian tubes cancer-free
OvC0561 62755 12 Cancer-free Fallopian tube fallopian tubes cancer-free
OvC0662 45114 10 IIIC, IVB, IA Peritoneum, Omentum, Ovarium 4HGSOC + 1HGSOC_clear cell carcinoma (mix)
OvC0711 59661 12 Cancer-free, IIIB, IIB, IC2, IIIC Ovarium HGSOC
OvC0863 18403 7 IIIC, IVB, IC1 Peritoneum, Omentum, Ovarium 7HGSOC + 1HGSOC_clear cell carcinoma (mix)
OvC0926 26703 6 IIIC Ovarium HGSOC
OvC1064 3827 1 NA NA HGSOC
OvC1120 101651 9 NA NA HGSOC
OvC1216 50396 5 III-IV Ovarium HGSOC
OvC1365 31969 8 NA Ovarium, Peritoneum, Relapse tumors 2HGSOC + 4LGSOC + SOC+Endometrioid
OvC1466 7554 3 NA Ovarium HGSOC

LGSOC Low-grade serous ovarian cancer.